November 2016
Greetings!
Today I'm pleased to share with you the final edition of the Updates for the Advanced Practitioner series on multiple myeloma for 2016. In this installment, I invite you to watch Chapter 10 of our roundtable video discussion, in which we look at new therapeutic agents for multiple myeloma recently approved by the FDA. You may also view the full-length video for the complete discussion I had with my fellow panel members.
The American Society of Hematology (ASH) annual meeting is coming up next month in San Diego. If you're able to attend, don't miss out on several of the myeloma-focused sessions! In anticipation of ASH, I've highlighted some meeting abstracts below and selected several clinically relevant papers in the News section.
As always, feel free to share this MM resource, the video roundtable discussion, and the JADPRO supplement with your colleagues. If you'd like to stay current and informed through the other Updates programs on the topics of HER2+ breast cancer and myeloproliferative neoplasms, you can access them on advancedpractitioner.com/updates.
I wish you all a happy and healthy Thanksgiving!
Beth Faiman, PhD, APN-BC, AOCN®
Multiple Myeloma Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio
